To access this element change to forms mode OFF
Grant Award View - GA207236
The development of industry-independent cancer clinical trial protocols
GA ID:
GA207236
Agency:
Cancer Australia
Approval Date:
21-Dec-2021
Publish Date:
23-Dec-2021
Category:
Cancer
Grant Term:
1-Jan-2022 to 30-Jun-2024
Value (AUD):
$1,375,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 21/22 Improved cancer control
Grant Program:
Support for Cancer Clinical Trials
Grant Activity:
The development of industry-independent cancer clinical trial protocols
Purpose:
|
Clinical trials benefit the community by improving the survival of people affected by cancer, and contribute to a reduction in premature death and disability. Clinical trials are fundamental to establishing if new cancer treatments, diagnostic tests or preventive interventions are effective and they help generate evidence for best-practice cancer care. |
GO ID:
GO Title:
Support for Cancer Clinical Trials Program Grant
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
Australia New Zealand Gynaecological Oncology Group
Recipient ABN:
69 138 649 028
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Sydney
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Postcode:
Multiple
Country:
AUSTRALIA